Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Non-Current Debt (2023 - 2025)

OptimizeRx's Non-Current Debt history spans 3 years, with the latest figure at $24.8 million for Q3 2025.

  • For Q3 2025, Non-Current Debt fell 25.47% year-over-year to $24.8 million; the TTM value through Sep 2025 reached $24.8 million, down 25.47%, while the annual FY2024 figure was $30.8 million, 9.98% down from the prior year.
  • Non-Current Debt for Q3 2025 was $24.8 million at OptimizeRx, down from $25.1 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $34.2 million in Q4 2023 and bottomed at $24.8 million in Q3 2025.
  • The 3-year median for Non-Current Debt is $31.6 million (2024), against an average of $30.3 million.
  • The largest YoY upside for Non-Current Debt was 9.94% in 2025 against a maximum downside of 25.47% in 2025.
  • A 3-year view of Non-Current Debt shows it stood at $34.2 million in 2023, then dropped by 9.98% to $30.8 million in 2024, then decreased by 19.52% to $24.8 million in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Non-Current Debt are $24.8 million (Q3 2025), $25.1 million (Q2 2025), and $29.2 million (Q1 2025).